Back to Search
Start Over
Recommendation for supportive care in patients receiving concurrent chemotherapy and radiotherapy for lung cancer
- Source :
- de Ruysscher, D, Faivre-Finn, C, Nackaerts, K, Jordan, K, Arends, J, Douillard, J-Y, Ricardi, U & Peters, S 2020, ' Recommendation for supportive care in patients receiving concurrent chemotherapy and radiotherapy for lung cancer ', Annals of Oncology, vol. 31, no. 1, pp. 41-49 . https://doi.org/10.1016/j.annonc.2019.10.003
- Publication Year :
- 2020
- Publisher :
- OXFORD UNIV PRESS, 2020.
-
Abstract
- Concurrent chemotherapy and radiotherapy (CCRT) followed by durvalumab immune therapy in appropriate patients is considered to be the standard of care in most fit stage III non-small-cell lung cancer (NSCLC) patients. However, CCRT is a toxic treatment that affects all organ systems and may cause acute and permanent side effects, some of which may be lethal. Supportive care is therefore of utmost importance in this clinical setting. A group of experts from the European Society for Therapeutic Radiology and Oncology (ESTRO) and the European Society of Medical Oncology (ESMO) identified the following items of importance for further improvement of supportive care: smoking cessation; nutrition before and during CCRT (including treatment and prevention of anorexia); physical exercise before and during CCRT; prevention and treatment of acute esophagitis and dysphagia; treatment of cough and dyspnea; treatment of skin reactions; treatment of fatigue; prophylaxis of nausea and emesis; prevention, diagnosis, and treatment of cardiac disease and damage; and optimization of radiotherapy techniques and chemotherapy adjustments to reduce toxicity in the era of immune therapy. The resulting recommendations are summarized in this manuscript and knowledge gaps identified, in which future investments are needed to improve supportive care and hence quality of life and survival for our stage III NSCLC patients. ispartof: ANNALS OF ONCOLOGY vol:31 issue:1 pages:41-49 ispartof: location:England status: published
- Subjects :
- 0301 basic medicine
medicine.medical_specialty
Durvalumab
Lung Neoplasms
Nausea
medicine.medical_treatment
Disease
PLACEBO-CONTROLLED TRIAL
FATIGUE
03 medical and health sciences
0302 clinical medicine
Quality of life (healthcare)
ESMO
ESTRO
guidelines
lung cancer
recommendations
supportive care
RADIATION-THERAPY
NUTRITIONAL MANAGEMENT
Carcinoma, Non-Small-Cell Lung
Antineoplastic Combined Chemotherapy Protocols
Medicine
Humans
Lung cancer
Intensive care medicine
AMERICAN SOCIETY
Chemotherapy
Manchester Cancer Research Centre
business.industry
INDUCED ESOPHAGITIS
ResearchInstitutes_Networks_Beacons/mcrc
Hematology
RANDOMIZED CONTROLLED-TRIAL
SMOKING-CESSATION
medicine.disease
DOUBLE-BLIND TRIAL
Therapeutic Radiology
Radiation therapy
030104 developmental biology
Oncology
030220 oncology & carcinogenesis
Quality of Life
Radiation Oncology
medicine.symptom
business
POSITION PAPER
Subjects
Details
- Language :
- English
- Database :
- OpenAIRE
- Journal :
- de Ruysscher, D, Faivre-Finn, C, Nackaerts, K, Jordan, K, Arends, J, Douillard, J-Y, Ricardi, U & Peters, S 2020, ' Recommendation for supportive care in patients receiving concurrent chemotherapy and radiotherapy for lung cancer ', Annals of Oncology, vol. 31, no. 1, pp. 41-49 . https://doi.org/10.1016/j.annonc.2019.10.003
- Accession number :
- edsair.doi.dedup.....b4cd9064cf4c8a61960a0d68df5ea168
- Full Text :
- https://doi.org/10.1016/j.annonc.2019.10.003